RT Journal Article
SR Electronic
T1 Management and containment of a SARS-CoV-2 Beta variant outbreak at the Malawi University of Science and Technology
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.25.21266298
DO 10.1101/2021.11.25.21266298
A1 Bandawe, Gama
A1 Chigwechokha, Petros
A1 Kunyenje, Precious
A1 Kazembe, Yohane
A1 Mwale, Jeverson
A1 Kamaliza, Madalitso
A1 Mpakati, Mtisunge
A1 Nyakanyaka, Yanjanani
A1 Makamo, Charles
A1 Kimu, Saizi
A1 Madanitsa, Mwayiwawo
A1 Bangoh, Joseph Bitilinyu
A1 Nyirenda, Tonney
A1 Luhanga, Richard
A1 Sambani, Martha
A1 Mvula, Benard
A1 Giandhari, Jennifer
A1 Pillay, Sureshnee
A1 Naidoo, Yeshnee
A1 Ramphal, Upasana
A1 San, James Emmanuel
A1 Tegally, Houriiyah
A1 Wilkinson, Eduan
A1 de Oliveira, Tulio
A1 Malata, Address
YR 2021
UL http://medrxiv.org/content/early/2021/11/28/2021.11.25.21266298.abstract
AB Outbreaks of COVID at university campuses can spread rapidly and threaten the broader community. We describe the management of an outbreak at a Malawian university in April-May 2021 during Malawi’s second wave. Classes were suspended following detection of infections by routine testing and campus-wide PCR mass testing was conducted. Fifty seven cases were recorded, 55 among students, two among staff. Classes resumed 28 days after suspension following two weeks without cases. Just 6.3% of full-time staff and 87.4% of outsourced staff tested while 65% of students at the main campus and 74% at the extension campus were tested. Final year students had significantly higher positivity and lower testing coverage compared to freshmen. All viruses sequenced were beta variant and at least four separate virus introductions onto campus were observed. These findings are useful for development of campus outbreak responses and indicate the need to emphasize staff, males and senior students in testing.Article Summary Line Successful management of a campus outbreak using test trace and isolate approach with resumption within a month following suspension of all in-person classes. Trends in voluntary testing by gender, age and year of study that can help in formation of future management approaches.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by the Malawi University of Science and Technology and the Malawi Government through the Ministry of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Malawi University of Science and Technology Research Ethics Committee (MUSTREC) IRB number IRB00012588 FWA00029630 determined that this study and analysis meets requirements for exemption from ethical review and approval, and informed consent was not required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors